Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS

Clinical trial NCT05829434 · WITHDRAWN

Trial details

NCT number: NCT05829434
Sponsor: Uwe Platzbecker
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Neoplasm

Start date: 2024-03-31
Primary completion: 2028-08-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.